We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanomedical Applications Global Market Worth $3.8 Billion by 2013

By LabMedica International staff writers
Posted on 03 Oct 2008
According to a new technical market research report, the global medical market for nanotechnology applications generated US$1.7 billion in 2007. More...
This is expected to increase to $1.9 billion in 2008, and $3.8 billion in 2013 for a compound annual growth rate (CAGR) of 14.9%. Furthermore, this market has the potential to reach $9.4 billion in 2018 at a CAGR of 19.9%.

According to BCC Research (Wellesley, MA, USA), a marketing research company, the market is broken down into the categories of nanoparticles, other nanostructured materials, and nanotools/nanodevices. Of these, the nanoparticles segment has the largest share of the market. Valued at $1.6 billion in 2007, this segment should increase at a CAGR of 13.4% to reach $1.8 billion in 2008 and $3.4 billion in 2013. Nanoparticles could potentially see $7.9 billion in revenue in 2018 with a CAGR of 18.6%.

Other nanostructured materials represent the next largest, and fastest growing, segment. Nanostructured materials generated $36.5 million in 2007 and an estimated $45.1 million in 2008. This should increase to $304.7 million in 2013 for a CAGR of 46.5%. This segment has the potential to reach $1.1 billion in 2018 at a CAGR of 29.4%.

Nanotools and nanodevices have the smallest share of the market, worth $30.5 million in 2007. This is expected to grow at a CAGR of 17.8% to reach $34.2 million in 2008 and $77.6 million in 2013. There is a potential for this segment to generate $287.5 million in 2018 at a CAGR of 29.9%.

Pharmaceutical applications currently dominate the market, according to BCC, accounting for nearly 90% of revenue in 2007, and this trend is expected to continue through 2008. This segment is expected to decrease to less than 70% of the market by 2013 and potentially near 50% of the market by 2018. Nanotechnology applications for medical research and medical devices are both expected to significantly gain in market share, potentially reaching 20% each by 2018.

BCC's market analysis delivers market research reports, newsletters, and conferences that provide companies with the insights needed to make intelligent and strategic business decisions.

Related Links:
BCC Research



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.